With regards to providing a treatment for OSA, the only real "solution" presently is the CPAP machine and Resmed has a monopoly in that market; they are currently valued at $10.2 billion (annual revenue of $AUD 3.88 billion). I know they're involved in a few other things but this is their primary source of revenue.
We can probably let our imaginations run wild when trying to predict what the market will value a successful OSA trial at based on these numbers
- Forums
- ASX - By Stock
- IHL
- Share your ideas and thoughts.
Share your ideas and thoughts., page-425
-
-
- There are more pages in this discussion • 266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)